baber/WOPTO huggingface dataset:
Patent NZ-523839-A (NZ)
Title: 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
Inventor: OGAWA MIKIO
IPC: A61P27/16
Filed: 2001-07-30
Abstract: 3,4-dihydroisoquinoline derivative compounds of formula (I) are disclosed. The compounds have cannabinoid (CB)2 receptor agonist activity and are useful as pharmaceutical agents for the prophylaxis and/or treatment of asthma, nasal allergy, atopic dermatology, autoimmune diseases, rheumatoid arthritis, immune dysfunction, postoperative pain, and cacinomatous pain.
Patent NZ-524420-A (NZ)
Title: Chemokine receptor binding heterocyclic compounds
Inventor: BRIDGER GARY
IPC: C07D401/12
Filed: 2001-09-17
Abstract: A compound of formula (I) and salts or pro-drug forms thereof, useful in the treatment of HIV or FIV infected patients by modulating a chemokine receptor such as CXCR4 or CCR5.
Patent NZ-528791-A (NZ)
Title: Albumin in a flexible polymeric container
Inventor: LEWIS JAMES D
IPC: B65B9/087
Filed: 2002-03-12
Abstract: A flexible polymeric container for holding albumin. The container is made of a sheet of flexible polymeric film formed into a bag having a cavity enclosed by a first wall, an opposing second wall, and seals about a periphery of the first and second walls. The seals join an interior portion of the opposing first and second walls and create a fluid-tight chamber within the cavity of the container for storing a concentration of the albumin. A method of packaging the albumin protein into a flexible polymeric container is also provided. Therein a flexible polymeric material is converted into bags, the bags are filled with a quantity of albumin by a filler, and a seal area of the bags is sealed to enclose the albumin within the bag.
Patent NZ-529328-A (NZ)
Title: System and method for production of a filled edible product
Inventor: ROTHAMEL RICHARD J
IPC: A23P1/12
Filed: 2000-01-27
Abstract: Disclosed herein is a method for producing the edible product which involves supplying the first and second edible materials to the extruder, and continuously coextruding the first and second materials as a longitudinal rope in which the first material is positioned within and surrounded by the second material, wherein the longitudinal rope is cut at spaced apart locations as it is being extruded from the extruder to produce individual edible products each containing an inner component comprised of the first material and an outer cover component comprised of the second material that substantially completely surrounds the inner component, with the edible products being sealed at opposite ends. Also disclosed is an edible product that involves an edible inner component made from a first material and an edible outer cover component substantially completely encapsulating the edible inner component is disclosed. In one embodiment, the inner component is in the form of a hairball treatment for cats and the outer component is a dough-like material. Furthermore a system is disclosed for producing the edible product includes a first material source for supplying a first edible material to form the inner component of the edible product, a second material source for supplying a second edible material to form the outer component of the edible product, and an extruder for continuously coextruding the first edible material and the edible second material to produce an elongated rope of edible product, wherein a crimping apparatus receives the longitudinal rope extruded from the extruder for crimping the longitudinal rope to separate the longitudinal rope into individual edible products. (62) Divided out of 513405
Patent NZ-536157-A (NZ)
Title: Phenolic ester compounds that liberate hydroxytyrosol or tyrosol after their hydrolysis, their use in the treatment of neurodegenerative disease
Inventor: GEERLINGS ARJAN
Filed: 2002-04-03
Abstract: A phenolic ester compound that liberates hydroxytyrosol or tyrosol after hydrolysis is disclosed, wherein the phenolic ester compound is selected from the group consisting of: 2-(3,4-dihydroxyphenyl) ethyl acetate (V), 2-(3,4-dihydroxyphenyl) ethyl oleate (VI), 2-(3,4-dihydroxyphenyl) ethyl stearate (VII), 2-(3,4-dihydroxyphenyl) ethyl docosahexaenoate (VIII), 2-(3,4-dihydroxyphenyl) ethyl eicosapentaenoate (IX), 2-(4-hydroxyphenyl) ethyl acetate (X), 2-(4-hydroxyphenyl) ethyl oleate (Xl), 2-(4-hydroxyphenyl) ethyl docosahexaenoate (XIII), 2-(4-hydroxyphenyl) ethyl eicosapentaenoate (XIV), 2-(3,4-diacetoxyphenyl) ethyl acetate (XV), 2-(3,4-dioleyloxyphenyl) ethyl oleate (XVI), 2-(3,4-distearyloxyphenyl) ethyl stearate (XVII), 2-(3,4-didocosahexaenoyloxyphenyl) ethyl docosahexaenoate (XVIII), 2-(3,4-dieicosapentaenoyloxyphenyl) ethyl eicosapentaenoate (XIX), 2-(4-acetoxyphenyl) ethyl acetate (XX), 2-(4-oleyloxyphenyl) ethyl oleate (XXI), 2-(4-stearyloxyphenyl) ethyl stearate (XXII), 2-(4-docosahexaenoyloxyphenyl) ethyl docosahexaenoate (XXIII), and 2-(4-eicosapentaenoyloxyphenyl) ethyl eicosapentaenoate (XXIV), wherein the phenolic ester compound is for use in the treatment or prevention of a neurodegenerative disease selected from the group consisting of Creutzfeldt-Jakob disease, Alzheimer's disease, Huntington's disease, Lewy body disease, Parkinson's disease, Pick's disease, amyotrophic lateral sclerosis, neurofibromatosis, brain injury, stroke, multiple sclerosis, loss of memory and multiple infarct dementia.
Patent NZ-538890-A (NZ)
Title: ACTN3 genotype screen for athletic performance
Inventor: NORTH KATHRYN NANCE
IPC: G16H20/30
Filed: 2003-09-15
Abstract: Disclosed is a method to predict athletic performance in a human individual comprising: a) screening the individual for the presence of a genetic variation in the codon encoding amino acid number 577 of the human alpha-actinin-3 (ACTN3) gene linked to athletic performance; and b) predicting athletic performance bases on the presence of a genetic variation, wherein: (i) genotyping the individual as a 577RR genotype is positively associated with sprinting or power performance, (ii) genotyping the individual as a 577XX genotype is negatively associated with sprinting or power performance, (iii) genotyping the individual as a 577XX genotype is positively associated with endurance performance, (iv) genotyping the individual as a 577RX genotype is positively associated with sprinting or power performance, and (v) genotyping the individual as 577RX genotype is negatively associated with endurance performance in female individuals.
Patent NZ-546496-A (NZ)
Title: Gas treatment process
Inventor: SIMPSON SEAN DENNIS
Filed: 2006-04-07
Abstract: Disclosed is a process for producing one or more alcohols from a gaseous substrate comprising CO, the process comprising the following steps, in any order: (a) in a bioreactor, anaerobically fermenting the gaseous substrate to produce one or more alcohols and acetate; (b) converting acetate obtained from step (a) into H2 and CO2 gases; and (c) using H2 and/or CO2 obtained from step (b) as a co-substrate in the fermentation process.
Patent NZ-551354-A (NZ)
Title: Treatment with oxaliplatin and erlotinib
Inventor: HIGGINS BRIAN
IPC: A61K33/243
Filed: 2005-05-25
Abstract: Disclosed is a pharmaceutical composition for use in treating cancer, consisting of erlotinib (an EGFR kinase inhibitor) and oxaliplatin, in a pharmaceutically acceptable carrier.
Patent NZ-551453-A (NZ)
Title: Nociceptin analogs for the treatment of pain
Inventor: SUN QUN
IPC: C07D263/58
Filed: 2002-04-18
Abstract: A compound of formula (III) that is useful for modulating a pharmacodynamic response from opioid receptors centrally and/or peripherally is disclosed, wherein: Z, D, R, R1, R2, and n are as described in the specification. These compounds are suitable for treating chronic and acute pain.
Patent NZ-563201-A (NZ)
Title: Underground and partly submerged pipe winding apparatus and method
Inventor: BATEMAN IAN ROGER
IPC: B29C63/32
Filed: 2006-04-10
Abstract: An apparatus and method for lining an underground conduit is disclosed. The apparatus (10) comprises: an annular frame (40) having a crown portion (42) and a base portion (49); a strip guide disposed around and supported by the annular frame (40), the guide arranged to guide a strip (12) around a helical path; a pair of strip pinch rollers mounted to the frame (40) at a position circumferentially about halfway between the crown portion (42) and the base portion (49); a drive assembly mounted to the frame for driving the strip (12) downwards into the helical path in a winding direction so as to present an incoming first edge to an adjacent second edge of a wound convolution of the strip; a liquid remover mounted to the frame, the liquid remover arranged to prevent liquid that has adhered to and ascended with the second edge from descending down towards the incoming first edge; and an extruder (80) mounted to the frame (40) for extruding a molten bead of plastic onto the strip (12) at a position just before the overlap.
Patent NZ-566864-A (NZ)
Title: Filter cleaning mechanism for a vcuum cleaner including means for deforming and quickly releasing a frame of the filter
Inventor: COBURN ERIC
Filed: 2008-03-20
Abstract: A filter cleaning mechanism and an associated method of cleaning a filter assembly are disclosed. The filter cleaning mechanism comprises a filter material (37) for filtering out dust and dirt particles from air, a frame (32, 34, 35, 38, 39) for supporting the filter material, and means for mechanically agitating the filter material to dislodge dust and dirt particles. The mechanical agitation means include a plurality of ramped means for deforming the frame within its elastic limit and a plurality of means for releasing the frame to an undeformed state. The ramped means for deforming the frame include: first means for deforming the frame in a longitudinal direction and second means for deforming the frame in a radial direction. The means for releasing the frame include: first means for releasing the frame in a longitudinal direction and second means for releasing the frame in a radial direction. In operation, the ramped face of each deforming means rides up an associated face of a release means producing a deformation in the frame. When the deforming means passes an end portion of the release means, its ramped face drops completely over the side, allowing the frame to spring back to its undeformed state. The spacing between first and second deforming means differs, as does the spacing between first and second release means.
Patent NZ-570379-A (NZ)
Title: Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
Inventor: LIN HAIXIANG
IPC: A61P31/00
Filed: 2006-06-27
Abstract: Disclosed is an immunogenic composition comprising: (a) a polynucleotide adjuvant comprising: a polyriboinosinic-polyribocytidylic acid (PIC), at least one antibiotic, and at least one positive ion; and (b) at least one antigen; wherein the said antigen is selected from the group consisting of: (i) a viral antigen selected from the group consisting of an adeniviridae, an arenaviridae, an astroviridae, a bunyaviridae, a cliciviridae, a flaviviridae, a hepatitis delta virus, a hepeviridae, a herpesviridae, a nidovirales, a piconavdae an orthomyxoviridae, a papillomaviridae, a parvoviridae, a polyomaviridae, a poxviridae, a reoviridae, a retroviridae and a togaviridae; (ii) a bacterial antigen selected from the group consisting of an actinobacteria, a chlamydiae, a firmicutes, a proteobacteria and a spirochaetes; (iii) a fungal antigen selected from the group consisting of an Ascomycota and a basidiomycota; (iv) a parasitic antigen selected from the group consisting of a phylum sarcomastigophora, a phylum apiicomplexa, a phylum ciliophora, a phylum plathyhelminthes, a phylum nematoda and a phylum arthropoda; (v) a cancer antigen selected from the group consisting of a bone, a brain, a breast, a digestive/gastrointestinal, an endocrine, an eye, a genitourinary, a germ a cell, a gynecologic, a head and neck, a hematological/blood, a lung, musculoskeletal, a neurologic, a respiratory/thoracic and a skin cancer.
Patent NZ-571534-A (NZ)
Title: An adjustable joist hanger
Inventor: CARR MICHAEL NORMAN
IPC: E04B1/38
Filed: 2008-09-25
Abstract: An adjustable bracket 10 for supporting a first building member extending in a first direction relative to a second building member extending in a second direction, the bracket 10 including a pair of bracket portions, each bracket portion having an attachment flange 13 oriented in a first plane, a side support 14 oriented in a second plane and a base wall oriented in a third plane, wherein the respective base walls of the pair of bracket portions are attached permanently to one another such that the separation distance between the side supports of the respective bracket portions is adjustable to accommodate different thickness of first building members there between, the base wall of one of the bracket portions includes one or more slot openings and one or more upstanding members are provided on the base wall of a second bracket portion, the upstanding members adapted to engage the slot openings and be slidable therein.
Patent NZ-572272-A (NZ)
Title: Grease trap with outer and inner tanks
Inventor: BATTEN WILLIAM C
IPC: B01D17/02
Filed: 2007-04-11
Abstract: A grease trap is disclosed for separating grease and solid waste from wastewater. The grease trap has a tank having a downwardly shaped bottom (44). An upwardly shaped divider (34) divides the tank into upper and lower chambers. A hole (36) near an upper part of the divider allows waste into the upper chamber. The tank has inlet (20) and outlet (22) inverts for wastewater. A pipe (38) extends through the hole in the divider into the lower chamber for removing solid waste.
Patent NZ-572512-A (NZ)
Title: Vessel closing laminate with a a free tab enabling ease of vessel opening
Inventor: SACHS VICTOR
IPC: B32B37/14
Filed: 2007-03-16
Abstract: A vessel (30) closing laminate is disclosed. The laminate is constructed from a seal laminate (3) having a bottom sub-assembly of layers including a foil layer and a seal substrate attached to the uppermost layer of the bottom subassembly of layers wherein the seal substrate has a bottom foam layer and a top plastic material layer. A free tab (50) lying wholly within the circumference of the seal assists in the removal of the laminate. A wax layer helps adhere an absorbent liner on top of the plastic material layer of the seal substrate.
Patent NZ-576901-A (NZ)
Title: Soil nail launcher
Inventor: RUCKMAN TIMOTHY ALLEN
IPC: E21D20/00
Filed: 2009-05-08
Abstract: Improvements to a soil nailing machine include that the communication or movement of gas from the annular space 146 between the inner 142 and outer 140 tubes of the barrel of the machine, and into which the compressed gas for driving the nail is input, to the passageway 130 that leads to the breach cavity 134 is through an area of connection 152 of the outer tube 140 and the breach 90 that is at least as large in area as the area of the annular space at a distal region of the barrel, so that the throttling of the gas flow is determined by the dimensions 132 of the passageway 130 rather than be some other dimension. Another improvement is the provision of a protective shroud attached at the opposite end of the barrel from the breach, the shroud including a plurality of curved shroud plates 84 attached to the outer surface of the shroud cage 80 and covering respective apertures 82 (for the exhaustion of gases) in the cage. The plates are arranged parallel to the cylindrical wall of the cage and fastened to the cage by bolts so that the edges of the plates are closer to the outer surface of the cage than the central portions of the plates.
Patent NZ-582166-A (NZ)
Title: Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration
Inventor: GRANCHA GAMON SALVADOR
IPC: A61K9/14
Filed: 2009-12-18
Abstract: Disclosed is a biocompatible composition for intravenous administration including microparticles of alginic acid or its salts for the controlled release of an encapsulated coagulation factor, characterised in that these microparticles are less than or equal to 5 micrometres in size and have a negative Z potential. A process to manufacture the above composition is also disclosed. Also disclosed is the use of the biocompatible composition in the manufacture of a medicament for treating bleeding disorders, coagulation changes and hormonal diseases.
Patent NZ-582871-A (NZ)
Title: 1,2,3,4-Tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5- tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof
Inventor: BAUDOIN BERNARD
IPC: A61K31/4985
Filed: 2008-07-24
Abstract: Disclosed are 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5- tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives as represented by the general formula (I), where p is an integer which may take the values 2 or 3; and where the other substituents are as defined herein. Also disclosed is the use of a compound as defined above for the preparation of a medicament intended for treating and/or for preventing Alzheimer's disease, Parkinson's disease, Down's syndrome, dementia with Lewy bodies, senile dementia, frontotemporal dementia, cerebral and systemic amyloidosis. mild cognitive impairments, cerebral amyloid angiopathy, primary and secondary memory disorders and cerebrovascular ischemia.
Patent NZ-582942-A (NZ)
Title: Use of kncq potassium channel openers for treating attention deficit hyperactivity disorder (adhd) or aggression
Inventor: BAK-JENSEN HENRIETTE HUSUM
IPC: A61P25/18
Filed: 2008-07-31
Abstract: Disclosed is the use of a compound in the manufacture of a pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) or aggression wherein the compound is selected from the group consisting of 2-cyclopentyl-N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-acetamide; N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide; N-(4,6-dimethyl-2-morpholin-4-yl-pyrimidin-5-yl)-2-(4-fluoro-phenyl)-acetamide; hexanoic acid (2,6-difluoro-4-morpholin-4-yl-phenyl)-amide; 2-cyclopentyl-N-(4,6-dimethyl-2-morpholin-4-yl-pyrimidin-5-yl)-acetamide; N-(2-bromo-4-morpholin-4-yl-6-trifluoromethyl-phenyl)-propionamide; N-(2,4-dimethyl-6-morpholin-4-yl-pyridin-3-yl)-3,3-dimethyI-butyramide; [2-amino-4-(2,4,6-trimethyl-benzylamino)-phenyl]-carbamic acid ethyl ester; and 2-cyclopentyl-N-(2-methoxy-6-methyl-4-morpholin-4-yl-phenyl)-acetamide; or a pharmaceutically acceptable salt thereof.
Patent NZ-585119-A (NZ)
Title: Medical injector with surrounding electrical field generating penetrating electrodes
Inventor: MASTERSON STEVEN P
IPC: A61N1/08
Filed: 2005-03-08
Abstract: A medical substance injector includes a fluid reservoir containing the therapeutic agent and a needle 252 or similar forming an injection orifice, an actuator 302 to force the agent from the reservoir through the orifice into the tissue of the patient, and a plurality of tissue penetrating electrodes 260 arranged in a predetermined spatial relationship. The reservoir, injector and penetrating electrode array are housed within a tool structure that includes an operator mechanism to inject the needle and the electrode array into the tissue of the patient in a predetermined spatial relationship. Once the needle is injected into the tissue a force of at least 1.1 Newtons is applied by an inanimate energy source to the actuator through the reservoir to the therapeutic agent, and once the electrode array is injected into the patient, an electrical source is connected to the electrodes so as to generate an electrical field around the injection site to facilitate the intracellular delivery of the therapeutic agent.
Patent NZ-587213-A (NZ)
Title: Handheld Dehider with details of counterbalance mass for rotating parts
Inventor: GWYTHER PETER
IPC: A22B5/16
Filed: 2006-09-14
Abstract: A dehider has counterbalance masses located on opposite sldes of an eccentric shaft (which drives counter-rotation discs by pushrods) so as to improve dynamic balance. Further details are disclosed. (62) Divided Out of 565564
Patent NZ-589809-A (NZ)
Title: Carcass cleaning method, device and machine
Inventor: HANSEN NIELS WORSOE
IPC: A22B5/00
Filed: 2008-05-16
Abstract: 589809 Disclosed is a cleaning device for cleaning a surface of a carcass by contact. The cleaning device has a number of steam discharge jets for discharging steam onto the surface of the carcass and a number of suction nozzles for drawing in impurities, steam and condensate from the surface of the carcass. The suction nozzles are adapted to follow an uneven surface of the carcass by deflecting resiliently when pressed against or swept across the carcass surface. The suction nozzles have additional openings or cut-outs for entry of ambient air arranged to enter at or near a mouth of the suction nozzle.
Patent NZ-590308-A (NZ)
Title: Methods and compositions for the treatment of cancer by inhibiting the programmed cell death 1 (pd-1) pathway
Inventor: FREEMAN GORDON
IPC: A61K39/395
Filed: 2006-06-08
Abstract: Disclosed is the use of a Programmed Cell Death-1 (PD-1) inhibitor in the manufacture of a medicament formulated to treat a tumor in a subject, wherein said PD-1 inhibitor is an anti-PD-1 antibody, an anti-PD-L1 antibody, an anti-PD-L2 antibody, an anti-PD-1 RNAi, an anti-PD-Ll RNAi, an anti-PD-L2 RNAi, an anti-PD-I antisense RNA, an anti-PD-L1 antisense RNA, an anti-PD-L2 antisense RNA, a dominant negative PD-1 protein, a dominant negative PD-L1 protein, or a dominant negative PD-L2 protein, wherein said tumor is angioimmunoblastic lymphoma, or nodular lymphocyte predominant Hodgkin's lymphoma.
Patent NZ-591171-A (NZ)
Title: Liquefaction of carbonaceous material using a pressurised superheated liquid
Inventor: O DOWD PETER JOHN
IPC: C10G1/06
Filed: 2009-07-28
Abstract: 591171 A carbonaceous material 30 liquefaction apparatus comprises a nozzle assembly 38 to supply a pressurised liquid with superheated or supercritical properties towards a carbonaceous material 30 as a high velocity liquid, a supply line 39, 46 to supply the pressurized liquid to the nozzle assembly 38, the high velocity liquid reacting with the carbonaceous material 30 to produce an upgraded or liquefied carbonaceous material 42, and a product return line to return the upgraded or liquefied carbonaceous material 42 and liquid to a processing plant the processing plant comprising a heat exchanger 44 to transfer heat from the product return line to the supply line 39, 46, a high pressure pump 48 to provide the pressurised liquid to the supply line 39, 46, a separator 52 in the product return line downstream of the heat exchanger 44 to separate gas 54 and oil product 56 from the upgraded or liquefied carbonaceous material and liquid 58, and a recycle line 64 to transfer at least part of the liquid from the separator 52 to the high pressure pump 48.
Patent NZ-592913-A (NZ)
Title: Composition for controlling plant diseases comprising ethaboxam and tolclofos-methyl
Inventor: KURAHASHI MAKOTO
IPC: A01N25/00
Filed: 2009-11-20
Abstract: Disclosed are compositions for controlling plant disease comprising ethaboxam and tolclofos-methyl. Further disclosed is a method for controlling plant diseases which comprises said composition, and a plant seed treated with effective amounts of said composition.
Patent NZ-593782-A (NZ)
Title: Compositions for drug administration comprising a triptan analog and an alkylsaccharide
Inventor: MAGGIO EDWARD T
IPC: A01N43/38
Filed: 2009-12-22
Abstract: Disclosed is a composition comprising: a.) A triptan analog selected from sumatriptan, naratriptan, eletriptan, frovatriptan, almotriptan, zolmitriptan, a salt thereof, or a combination thereof; and b.) An alkylsaccharide, wherein the alkylsaccharide has an alkyl chain including between 10 to 16 carbon atoms, such as undecyl-beta-D-maltoside, dodecyl-beta-D-maltoside, tridecyl-beta-D-maltoside, tetradecyl-beta-D-maltoside, sucrose mono-dodecanoate, or a combination thereof.